Vladimir Putin in Serbia, October 2014

Russian President Vladimir Putin announced today (August 11) that his country had won the global race to approve a vaccine against COVID-19, several news outlets have reported. Despite having only been in clinical trials for less than two months, the vaccine developed by the Gamaleya Institute in Moscow is safe, Putin said at a televised cabinet meeting, noting that it has already been given to one of his daughters, according to Reuters and The Washington Post. The government plans to first vaccinate high-risk groups such as healthcare workers and teachers, with mass vaccination starting in October after large-scale production begins, according to the Associated Press.

“It works effectively enough, forms a stable immunity and, I repeat, it has gone through all necessary tests,” Putin said at the meeting, according to The New York Times.

Researchers around...

“The collateral damage from release of any vaccine that was less than safe and effective would exacerbate our current problems insurmountably,” agrees Imperial College London immunologist Danny Altmann in a statement quoted by several news outlets.

The vaccine uses an adenovirus vector studded with SARS-CoV-2 spike proteins. According to the AP, Kirill Dmitriev, chief executive of the Russian Direct Investment Fund, told reporters this week that Phase 3 testing in the UAE, Saudia Arabia, the Philippines, and elsewhere could start as early as tomorrow and include “several thousand people.”

See “COVID Vaccine Frontrunners

The World Health Organization (WHO), which last week urged Russia to follow international COVID vaccine development guidelines, according to the BBC, says it’s now in talks with the country for a possible “WHO prequalification,” according to Reuters.

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!